News

Mylan Completes Acquisition of Renaissance’s Leading Topicals-Focused Specialty and Generics Business

ERTFORDSHIRE, England and PITTSBURGH, June 15, 2016 /PRNewswire/ — Mylan N.V. (NASDAQ, TASE: MYL) today announced that it has successfully completed the acquisition of the non-sterile, topicals-focused specialty and generics business (the “Business”) of Renaissance Acquisition Holdings, LLC (“Renaissance”). The Business brings Mylan an attractive and complementary […]

Read more

Mylan to Acquire Renaissance’s Leading Topicals-Focused Specialty and Generics Business

Transaction Immediately Accretive to Adjusted Diluted EPS HERTFORDSHIRE, England and PITTSBURGH – May 13, 2016 – Mylan N.V. (NASDAQ, TASE: MYL) today announced an agreement to acquire the non-sterile, topicals-focused specialty and generics business (the “Business”) of Renaissance Acquisition Holdings, LLC (“Renaissance”) for $950 million in cash […]

Read more

DPT and Confab Complete $10 Million Capital Investment in San Antonio and Montreal

(San Antonio, March 8, 2016) — DPT Laboratories, a contract development and manufacturing organization (CDMO) specializing in semi-solid and liquid dosage forms, and Confab, a DPT company specializing in complex solids, semi-solids and liquids, have completed a combined $10 million capital investment demonstrating their commitment to continuous […]

Read more

Industry Expert Carolyn Gudz Joins Expanding Confab Team

(Saint-Hubert, QC, Canada) — Confab, a leading contract development and manufacturing organization (CDMO) specializing in the pharmaceutical development of semi-solid and solid dosage forms, including tablet, capsule and suppository manufacturing, has named Carolyn Gudz, MBA, as senior director of business development and customer service. The appointment further […]

Read more

DPT Laboratories, Confab Announce Integration

(San Antonio, TX) — Pharmaceutical contract development and manufacturing organizations (CDMOs) DPT Laboratories, based in San Antonio, Texas, and Confab, based in Saint-Hubert, Quebec, today announced the integration of the organizations under the leadership of Paul Johnson, Group President and COO. Both DPT and Confab are owned […]

Read more

Renaissance and GlaxoSmithKline Agree to A Transfer of Nine Products

(Montreal, QC, Lake Forest, IL, Newton, PA, and Research Triangle Park, NC) — Renaissance Acquisition Holdings, LLC (“Renaissance”) a RoundTable Healthcare Partners (“RoundTable”) portfolio company, and GlaxoSmithKline (LSE/NYSE: GSK) announced today that they have entered into an agreement giving Renaissance the rights in the USA to manufacture, […]

Read more

Confab Launches New Website and Plans to Exhibit at Interphex 2013

(Saint-Hubert, QC, Canada) — Confab is pleased to announce the launch of their new website confab.com in both English and French versions. New features of the website include a completely new site layout, revamped corporate branding and more. Some of the goals with the new website were […]

Read more

Confab named Pharmaceutical Manufacturing Leader by Life Science Leader Magazine

Confab wins the CMO Leadership award for both Quality and Reliability. These two awards were granted in the three following categories : Solids Semi-solids Liquid Manufacturing

Read more

New Employee

Confab Laboratories Inc. announced today that Mrs. France Montgrain has joined the Confab Executive Team as Vice-President Business Development and Quality Operations. “We are very pleased to bring her aboard. Her 26 years of experience in the pharmaceutical industry will strengthen our team from a business development […]

Read more

Canadian Leader

“As a remarkable entrepreneur for over 3 decades, Guy Lamarre has built Confab into a globally recognized successful private manufacturer of pharmaceuticals in Canada. We are very pleased to recognize Guy as our 2011 Canadian Leader for the pharmaceutical industry.” – Pharma & BioPharma Canada, 2011 Industry […]

Read more